Literature DB >> 6275118

Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo.

M Barbacid, A V Lauver.   

Abstract

The primary translational product of the McDonough (SM) strain of feline sarcoma virus (FeSV) is a 180,000-dalton molecule, SM P180, that contains the p15-p12-p30 region of the FeLV gag gene-coded precursor protein and a sarcoma virus-specific polypeptide. In addition, cells transformed by SM-FeSV express a 120,000-dalton molecule, SM P120, that is highly related to the non-helper virus domain of SM P180. Both SM-FeSV gene products were found to be intimately associated with the membrane fraction of SM-FeSV-transformed cells. Immunoprecipitates containing SM P180 and SM P120 exhibited a protein kinase activity capable of phosphorylating tyrosine residues of both viral gene products but not immune immunoglobulin G molecules. By independently immunoprecipitating each of the two SM-FeSV proteins we found that most of the tyrosine-specific phosphorylating activity was associated with the SM P120 molecule. In vivo analysis of 32P-labeled SM P180 and SM P120 revealed their phosphoprotein nature; however, both molecules exhibited low levels of phosphorylation and did not contain phosphotyrosine residues. Finally, we did not detect any significant elevation in the levels of phosphotyrosine in the protein fraction of SM-FeSV transformants. Thus, if SM-FeSV were to induce malignant transformation by a mechanism involving phosphorylation of tyrosine residues, the viral gene products must interact with a small subset of cellular proteins that do not represent a significant fraction of the total cellular protein content.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275118      PMCID: PMC256692     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Defectiveness of a feline sarcoma virus demonstrable by the acquisition of a new envelope antigenic type by phenotypic mixing.

Authors:  P S Garma; T Log
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

2.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

3.  Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.

Authors:  O N Witte; N Rosenberg; M Paskind; A Shields; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein.

Authors:  A D Levinson; H Oppermann; L Levintow; H E Varmus; J M Bishop
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

5.  Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses.

Authors:  I C Henderson; M M Lieber; G J Todaro
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

6.  Studies on the formation of the influenza virus envelope.

Authors:  A J Hay
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

7.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

8.  Experimental transmission of feline fibrosarcoma to cats and dogs.

Authors:  M B Gardner; R W Rongey; P Arnstein; J D Estes; P Sarma; R J Huebner; C G Rickard
Journal:  Nature       Date:  1970-05-30       Impact factor: 49.962

9.  Transmissible feline fibrosarcoma.

Authors:  S P Snyder; G H Theilen
Journal:  Nature       Date:  1969-03-15       Impact factor: 49.962

10.  A transmissible feline fibrosarcoma of viral origin.

Authors:  S K McDonough; S Larsen; R S Brodey; N D Stock; W D Hardy
Journal:  Cancer Res       Date:  1971-07       Impact factor: 12.701

View more
  22 in total

1.  Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis.

Authors:  S D Lyman; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

2.  Tyrosine phosphorylations in vivo associated with v-fms transformation.

Authors:  D K Morrison; P J Browning; M F White; T M Roberts
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.

Authors:  G Mitra; D Martin-Zanca; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.

Authors:  E F Wheeler; M F Roussel; A Hampe; M H Walker; V A Fried; A T Look; C W Rettenmier; C J Sherr
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.

Authors:  P J Browning; H F Bunn; A Cline; M Shuman; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  FMS mutations in myelodysplastic, leukemic, and normal subjects.

Authors:  S A Ridge; M Worwood; D Oscier; A Jacobs; R A Padua
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Monoclonal antibodies specific to transforming polyproteins encoded by independent isolates of feline sarcoma virus.

Authors:  F Veronese; G J Kelloff; F H Reynolds; R W Hill; J R Stephenson
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

8.  Subcellular localization of glycoproteins encoded by the viral oncogene v-fms.

Authors:  S J Anderson; M A Gonda; C W Rettenmier; C J Sherr
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

9.  Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms.

Authors:  S J Anderson; M Furth; L Wolff; S K Ruscetti; C J Sherr
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

10.  Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

Authors:  A Hampe; M Gobet; C J Sherr; F Galibert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.